Skip to content
PubMed This is a summary of 50 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 50 referenced papers

Top Authors

Bart P.C. van de Warrenburg
Radboud University Nijmegen
Filippo Maria Santorelli
Fondazione Stella Maris
Alexander C. H. Geurts
Radboud University Nijmegen
Vivian Weerdesteyn
Radboud University Nijmegen
Bas J. H. van Lith
Radboud University Nijmegen
Rebecca Schüle
German Center for Neurodegenerative Diseases
Marcondes C. França
Universidade Estadual de Campinas (UNICAMP)
Jürgen Winkler
Friedrich-Alexander-Universität Erlangen-Nürnberg
Martin Regensburger
Friedrich-Alexander-Universität Erlangen-Nürnberg
Giovanni Stévanin
Centre National de la Recherche Scientifique

Top Institutions

Ranked by publications Top 10 institutions

References

References (50)
  1. 1

    Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia.

    de Niet M, de Bot ST, van de Warrenburg BP, et al.

    Journal of rehabilitation medicine 2015; (47(2)):147-53 doi:10.2340/16501977-1909.

    PMID: 25325386
  2. 2

    Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations.

    Servelhere KR, Faber I, Saute JA, et al.

    European journal of neurology 2016; (23(2)):408-11 doi:10.1111/ene.12839.

    PMID: 26806216
  3. 3

    Selective dorsal rhizotomy for hereditary spastic paraparesis in children.

    Sharma J, Bonfield C, Steinbok P

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2016; (32(8)):1489-94 doi:10.1007/s00381-016-3122-2.

    PMID: 27312078
  4. 4

    Pathophysiology, diagnostic work-up and management of balance impairments and falls in patients with hereditary spastic paraplegia.

    Nonnekes J, van Lith B, van de Warrenburg BP, et al.

    Journal of rehabilitation medicine 2017; (49(5)):369-377 doi:10.2340/16501977-2227.

    PMID: 28471471
  5. 5

    Gastrointestinal and urinary complaints in adults with hereditary spastic paraparesis.

    Kanavin ØJ, Fjermestad KW

    Orphanet journal of rare diseases 2018; (13(1)):58 doi:10.1186/s13023-018-0804-8.

    PMID: 29661209
  6. 6

    Lower Urinary Tract Function in Familial Spastic Paraplegia.

    Sakakibara R, Shimizu A, Takahashi O, et al.

    European neurology 2018; (80(3-4)):121-125 doi:10.1159/000494030.

    PMID: 30391939
  7. 7

    "Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia.

    Pascual B, de Bot ST, Daniels MR, et al.

    AJNR. American journal of neuroradiology 2019; (40(1)):199-203 doi:10.3174/ajnr.A5935.

    PMID: 30606727
  8. 8

    Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature.

    Bellofatto M, De Michele G, Iovino A, et al.

    Frontiers in neurology 2019; (10()):3 doi:10.3389/fneur.2019.00003.

    PMID: 30723448
  9. 9

    The genetic etiology in cerebral palsy mimics: The results from a Greek tertiary care center.

    Zouvelou V, Yubero D, Apostolakopoulou L, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2019; (23(3)):427-437 doi:10.1016/j.ejpn.2019.02.001.

    PMID: 30799092
  10. 10

    Urological dysfunction in patients with hereditary spastic paraplegia.

    Joussain C, Levy J, Charlanes A, et al.

    Neurourology and urodynamics 2019; (38(4)):1081-1085 doi:10.1002/nau.23957.

    PMID: 30848841
  11. 11

    Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia.

    van Lith BJH, den Boer J, van de Warrenburg BPC, et al.

    Journal of rehabilitation medicine 2019; (51(6)):434-441 doi:10.2340/16501977-2556.

    PMID: 30968942
  12. 12

    Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia.

    Kerstens HCJW, Satink T, Nijkrake MJ, et al.

    Disability and rehabilitation 2020; (42(26)):3744-3751 doi:10.1080/09638288.2019.1610084.

    PMID: 31079503
  13. 13

    Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome Sequencing.

    Kim A, Kumar KR, Davis RL, et al.

    Cerebellum (London, England) 2019; (18(4)):781-790 doi:10.1007/s12311-019-01038-0.

    PMID: 31104286
  14. 14

    Treatable cause of hereditary spastic paraplegia: eight cases of combined homocysteinaemia with methylmalonic aciduria.

    Wei Y, Zhou Y, Yuan J, et al.

    Journal of neurology 2019; (266(10)):2434-2439 doi:10.1007/s00415-019-09432-8.

    PMID: 31203424
  15. 15

    Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?

    Jacinto-Scudeiro LA, Dariva Machado G, Ayres A, et al.

    Frontiers in neurology 2019; (10()):508 doi:10.3389/fneur.2019.00508.

    PMID: 31231294
  16. 16

    Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).

    Rattay TW, Boldt A, Völker M, et al.

    Journal of neurology 2020; (267(2)):369-379 doi:10.1007/s00415-019-09573-w.

    PMID: 31646384
  17. 17

    Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands.

    van Lith BJH, Kerstens HCJW, van den Bemd LAC, et al.

    Orphanet journal of rare diseases 2020; (15(1)):64 doi:10.1186/s13023-020-1338-4.

    PMID: 32131864
  18. 18

    Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia.

    Paparella G, Vavla M, Bernardi L, et al.

    Frontiers in neuroscience 2020; (14()):111 doi:10.3389/fnins.2020.00111.

    PMID: 32153352
  19. 19

    Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients.

    Du J

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021; (85()):67-71 doi:10.1016/j.jocn.2020.11.036.

    PMID: 33581793
  20. 20

    Neuroimaging patterns in paediatric onset hereditary spastic paraplegias.

    Dosi C, Pasquariello R, Ticci C, et al.

    Journal of the neurological sciences 2021; (425()):117441 doi:10.1016/j.jns.2021.117441.

    PMID: 33866115
  21. 21

    Disease Severity and Motor Impairment Correlate With Health-Related Quality of Life in AP-4-Associated Hereditary Spastic Paraplegia.

    Jordan C, Geisel G, Alecu JE, et al.

    Neurology. Genetics 2021; (7(4)):e605 doi:10.1212/NXG.0000000000000605.

    PMID: 34295967
  22. 22

    Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.

    Ebrahimi-Fakhari D, Alecu JE, Ziegler M, et al.

    Neurology 2021; (97(19)):e1942-e1954 doi:10.1212/WNL.0000000000012836.

    PMID: 34544818
  23. 23

    The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: A case series.

    Pointon R, Whelan H, Raza R, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2022; (36()):14-18 doi:10.1016/j.ejpn.2021.11.003.

    PMID: 34794088
  24. 24

    Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia.

    Méreaux JL, Banneau G, Papin M, et al.

    Brain : a journal of neurology 2022; (145(3)):1029-1037 doi:10.1093/brain/awab386.

    PMID: 34983064
  25. 25

    Infantile onset ascending hereditary spastic paralysis.

    Eltoum A, O'Rourke D, Sharif F

    BMJ case reports 2022; (15(1)) doi:10.1136/bcr-2020-240941.

    PMID: 35039335
  26. 26

    Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

    Teive HAG, Camargo CHF, Pereira ER, et al.

    Neurogenetics 2022; (23(3)):167-177 doi:10.1007/s10048-022-00688-3.

    PMID: 35397036
  27. 27

    Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.

    Chen J, Zhao Z, Shen H, et al.

    BMC neurology 2022; (22(1)):180 doi:10.1186/s12883-022-02708-z.

    PMID: 35578252
  28. 28

    Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia.

    Utz KS, Kohl Z, Marterstock DC, et al.

    Orphanet journal of rare diseases 2022; (17(1)):301 doi:10.1186/s13023-022-02451-1.

    PMID: 35906604
  29. 29

    Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.

    Mo A, Saffari A, Kellner M, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(12)):2440-2446 doi:10.1002/mds.29225.

    PMID: 36103453
  30. 30

    Arginase 1 Deficiency in Patients Initially Diagnosed with Hereditary Spastic Paraplegia.

    McNutt MC, Foreman N, Gotway G

    Movement disorders clinical practice 2023; (10(1)):109-114 doi:10.1002/mdc3.13612.

    PMID: 36698992
  31. 31

    AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model.

    Deng R, Medico-Salsench E, Nikoncuk A, et al.

    Acta neuropathologica 2023; (146(2)):353-368 doi:10.1007/s00401-023-02579-9.

    PMID: 37119330
  32. 32

    Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.

    Siow SF, Yeow D, Rudaks LI, et al.

    Genes 2023; (14(9)) doi:10.3390/genes14091756.

    PMID: 37761896
  33. 33

    Surgical treatment options for spasticity in children and adolescents with hereditary spastic paraplegia.

    van de Pol LA, Burgert N, van Schie PEM, et al.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2024; (40(3)):855-861 doi:10.1007/s00381-023-06159-w.

    PMID: 37783799
  34. 34

    The therapeutic effects of physical treatment for patients with hereditary spastic paraplegia: a narrative review.

    Di Ludovico A, Ciarelli F, La Bella S, et al.

    Frontiers in neurology 2023; (14()):1292527 doi:10.3389/fneur.2023.1292527.

    PMID: 38093754
  35. 35

    Intrathecal baclofen for the management of hereditary spastic paraparesis: a systematic review.

    Viana Pinto L, Romeiro I, Gouveia F, et al.

    International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation 2024; (47(1)):3-9 doi:10.1097/MRR.0000000000000607.

    PMID: 38251093
  36. 36

    Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia.

    Ibrahim AA, Ollenschläger M, Klebe S, et al.

    European journal of neurology 2024; (31(8)):e16367 doi:10.1111/ene.16367.

    PMID: 38859620
  37. 37

    Preoperative gait pattern as predictor of gait changes following selective dorsal rhizotomy.

    van Dijk LMM, Veerkamp K, van der Krogt MM, et al.

    Gait & posture 2025; (117()):363-371 doi:10.1016/j.gaitpost.2025.01.017.

    PMID: 39889620
  38. 38

    Gait Training for Walking Acquisition in a Child with Hereditary Spastic Paraplegia: A Case Report.

    Abe H, Hanamachi M

    Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association 2025; (37(3)):390-395 doi:10.1097/PEP.0000000000001208.

    PMID: 40227975
  39. 39

    French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

    Mania-Pâris L, Ewenczyk C, Nicolas G, et al.

    Revue neurologique 2025; (181(6)):471-482 doi:10.1016/j.neurol.2025.05.001.

    PMID: 40450402
  40. 40

    Experience in the clinical and genetic diagnosis of a series of Algerian patients with hereditary spastic paraplegias.

    Messaoud-Khelifi M, Boulariah-Hadjou R, Kediha MI, et al.

    Neurogenetics 2025; (26(1)):52 doi:10.1007/s10048-025-00833-8.

    PMID: 40560206
  41. 41

    The cognitive profile of hereditary spastic paraplegia: a systematic review of the literature.

    Quinzi A, Capogna E, Guidi L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(12)):6393-6416 doi:10.1007/s10072-025-08408-z.

    PMID: 41032233
  42. 42

    Effect of an evidence-based modified developmental physiotherapy intervention on muscle tone, motor functions, and trunk control in a child with hereditary spastic paraplegia type 47: A case report.

    Sırrı B

    Physiotherapy theory and practice 2026; (42(8)):1120-1129 doi:10.1080/09593985.2026.2615379.

    PMID: 41524140
  43. 43

    Cognitive impairment in hereditary spastic paraparesis: An overlooked aspect of a motor disorder.

    Falcone GMI, Bonanno L, Graceffa AMS, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(2)):199 doi:10.1007/s10072-026-08830-x.

    PMID: 41586951
  44. 44

    Selective Dorsal Rhizotomy in Children with Hereditary Spastic Paraplegia.

    Stanton AN, Fredricks NS, Price AM, et al.

    Pediatric neurosurgery 2026; 1-8 doi:10.1159/000551915.

    PMID: 41961756
  45. 45

    "Effects of robot-assisted gait training combined with traditional treatment in hereditary spastic paraplegia: An observational pilot cohort study".

    Diella E, Malerba G, Biffi E, et al.

    Scientific reports 2026; (16(1)).

    PMID: 42265415
  46. 46

    Genotypic and Phenotypic Profile of Hereditary Spastic Paraplegia in Children: A Single-Centre Study from Northern India.

    Das N, Shambhavi A, Sait H, et al.

    Indian pediatrics 2026; doi:10.1007/s13312-026-00403-7.

    PMID: 42490029
  47. 47

    Walking aids to improve gait in hereditary spastic paraplegia - effects and predictive parameters in a short-term sensor-based evaluation.

    Kotter K, Ibrahim A, Koch V, et al.

    Neurodegenerative disease management 2026; 1-11 doi:10.1080/17582024.2026.2713717.

    PMID: 42558011
  48. 48

    Hereditary spastic paraplegia: a practical approach.

    Bradley M, Kalfat A, Walsh RA, et al.

    Practical neurology 2026; doi:10.1136/pn-2026-005344.

    PMID: 42816178
  49. 49

    Rehabilitation management of children with hereditary spastic paraplegia: a retrospective cohort study.

    Paget SP, McIntyre S, Lewis J, et al.

    Developmental neurorehabilitation 2026; 1-8 doi:10.1080/17518423.2026.2738682.

    PMID: 42831377
  50. 50

    Childhood-onset hereditary spastic paraplegia: at the crossroads between neurodevelopment and neurodegeneration.

    Espasandin-Hueter N, Salazar-Villacorta A, Escudero JM, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (65()):50-65 doi:10.1016/j.ejpn.2026.10.002.

    PMID: 42976539